IMUX
Immunic·NASDAQ
--
--(--)
--
--(--)
5.37 / 10
Netural
Money flow analysis registers 7.53/10, showing robust fund flow characteristics. Positive momentum in Small is countered by negative tendencies in overall, block, Medium, Large, and Extra-large, suggesting positive flow conditions. Analyst coverage indicates overwhelmingly bullish analyst consensus with strong conviction. Rating distribution: Strong Buy(100.0%) among 1 analysts, supported by 3.21 historical weighted rating.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-01-07
InstitutionD. Boral Capital
Times predicted12
Historical Win Rate25.0%
What is the analyst consensus for IMUX?
- IMUX holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 5.37/10 (Netural).
